SUJAY KANGO - 29 Sep 2023 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role
Director
Signature
/s/ David M. Urso, as attorney in fact
Issuer symbol
MEIP
Transactions as of
29 Sep 2023
Net transactions value
$0
Form type
4
Filing time
12 Oct 2023, 19:39:15 UTC
Previous filing
07 Jul 2022
Next filing
05 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEIP Stock Option (Right to Buy) Award $0 +10,000 $0.000000 10,000 29 Sep 2023 Common Stock 10,000 $7.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Such option shall vest as follows: 16.66666% shall be vested on the date of grant, and the remaining shares subject to the option shall vest in equal monthly amounts beginning October 1, 2023 and continuing on the first day of each calendar month following such date and continuing through July 1, 2024.